World's Best Scientists 2026 revealed!
VIEW LIST
Eric K. Rowinsky

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 98 8751 8214 4511 4171 421 53836

Eric K. Rowinsky publications per year

The chart shows the history of publications by Eric K. Rowinsky between 1985 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Eric K. Rowinsky published across 41 years, from 1985 to 2025, averaging 10.8 papers a year. Output peaked at 65 publications in 2004. 7 of the 441 publications appeared in the last two years.

No. of publications
20 40 60
Bar chart. Horizontal axis: year, 1985 to 2025. Vertical axis: number of publications, 0 to 65. Peak 65 publications in 2004. 1985: 1 publication 1986: 2 publications 1987: 4 publications 1988: 4 publications 1989: 6 publications 1990: 7 publications 1991: 7 publications 1992: 6 publications 1993: 13 publications 1994: 9 publications 1995: 12 publications 1996: 16 publications 1997: 13 publications 1998: 12 publications 1999: 15 publications 2000: 20 publications 2001: 15 publications 2002: 11 publications 2003: 21 publications 2004: 65 publications 2005: 16 publications 2006: 24 publications 2007: 16 publications 2008: 16 publications 2009: 10 publications 2010: 17 publications 2011: 12 publications 2012: 9 publications 2013: 8 publications 2014: 10 publications 2015: 7 publications 2016: 2 publications 2017: 2 publications 2018: 4 publications 2019: 0 publications 2020: 5 publications 2021: 3 publications 2022: 4 publications 2023: 10 publications 2024: 5 publications 2025: 2 publications
1985 2025

441 publications in total across all disciplines

View publications per year as a table
Eric K. Rowinsky: publications per year, 1985 to 2025
Year Publications
1985 1
1986 2
1987 4
1988 4
1989 6
1990 7
1991 7
1992 6
1993 13
1994 9
1995 12
1996 16
1997 13
1998 12
1999 15
2000 20
2001 15
2002 11
2003 21
2004 65
2005 16
2006 24
2007 16
2008 16
2009 10
2010 17
2011 12
2012 9
2013 8
2014 10
2015 7
2016 2
2017 2
2018 4
2019 0
2020 5
2021 3
2022 4
2023 10
2024 5
2025 2
Total 441
Download as CSV

Eric K. Rowinsky publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Eric K. Rowinsky sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 421–440 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 421 publications — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806 421
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Eric K. Rowinsky D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Eric K. Rowinsky sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 98–99 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 98 D-Index — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668 98
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Eric K. Rowinsky is affiliated with Eli Lilly in the United States and has contributed extensively to research in medicine, with a focus on oncology and related subfields. Their work spans various aspects of cancer research, immunology, biotechnology, and genetics, with a significant emphasis on CAR-T cell therapy and virus-based gene therapies.

Rowinsky's research portfolio includes 31 publications in medicine and 17 in biochemistry, genetics, and molecular biology. Among the primary subfields addressed are oncology, immunology, biotechnology, genetics, and radiology, nuclear medicine, and imaging. The scientist's main topics of investigation cover:

  • CAR-T cell therapy research
  • Cancer Research and Treatments
  • Virus-based gene therapy research
  • Biosimilars and Bioanalytical Methods
  • Monoclonal and Polyclonal Antibodies Research
  • Cancer Immunotherapy and Biomarkers
  • Immune cells in cancer

Rowinsky has published in several scientific venues, with the most frequent being the Journal of Clinical Oncology (9 papers), followed by Cancer Research (5), Regular and Young Investigator Award Abstracts (2), Investigational New Drugs (1), and The Lancet Oncology (1).

Notable recent papers include:

  • "Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma," 2020, Investigational New Drugs
  • "LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study," 2024, The Lancet Oncology
  • "Chimeric Antigen Receptor T Cells Targeting CD19 and GCC in Metastatic Colorectal Cancer," 2024, JAMA Oncology
  • "A phase I/II study of LOAd703, a TMZ-CD40L/4-1BBL-armed oncolytic adenovirus, combined with nab-paclitaxel and gemcitabine in advanced pancreatic cancer," 2022, Journal of Clinical Oncology
  • "A phase I/II study combining a TMZ-CD40L/4-1BBL-armed oncolytic adenovirus and nab-paclitaxel/gemcitabine chemotherapy in advanced pancreatic cancer: An interim report," 2020, Journal of Clinical Oncology

The scientist collaborates frequently with researchers such as Marwan Fakih, Jessica Wenthe, Emma Eriksson, Gustav Ullenhag, and Dongqi Chen, each representing recurrent contributions to related research themes and clinical studies.

Best Publications

  • Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck

    James A. Bonner;Paul M. Harari;Jordi Giralt;Nozar Azarnia

  • Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.

    James A Bonner;Paul M Harari;Jordi Giralt;Roger B Cohen

  • Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms.

    William P. McGuire;Eric K. Rowinsky;Neil B. Rosenshein;Francis C. Grumbine

  • Determinants of Tumor Response and Survival With Erlotinib in Patients With Non—Small-Cell Lung Cancer

    Román Pérez-Soler;Abraham Chachoua;Lisa A. Hammond;Eric K. Rowinsky

  • Taxol: A Novel Investigational Antimicrotubule Agent

    Eric K. Rowinsky;Lorranie A. Cazenave;Ross C. Donehower

  • Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma

    Mark J. Ratain;Tim Eisen;Walter M. Stadler;Keith T. Flaherty

  • Phase I and Pharmacologic Study of OSI-774, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced Solid Malignancies

    Manuel Hidalgo;Lillian L. Siu;John Nemunaitis;Jinee Rizzo

  • ZD1839, a Selective Oral Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor, Is Well Tolerated and Active in Patients With Solid, Malignant Tumors: Results of a Phase I Trial

    Malcolm R Ranson;Lisa A Hammond;David R Ferry;Mark Kris

  • Clinical toxicities encountered with paclitaxel (Taxol)

    Rowinsky Ek;Eisenhauer Ea;Chaudhry;Arbuck Sg

  • Phase III Trial of Doxorubicin, Paclitaxel, and the Combination of Doxorubicin and Paclitaxel as Front-Line Chemotherapy for Metastatic Breast Cancer: An Intergroup Trial (E1193)

    George W. Sledge;Donna Neuberg;Patricia Bernardo;James N. Ingle

  • Comparison of Survival and Quality of Life in Advanced Non–Small-Cell Lung Cancer Patients Treated With Two Dose Levels of Paclitaxel Combined With Cisplatin Versus Etoposide With Cisplatin: Results of an Eastern Cooperative Oncology Group Trial

    Philip Bonomi;KyungMann Kim;Diane Fairclough;David Cella

  • The Current Status of Camptothecin Analogues as Antitumor Agents

    William J. Slichenmyer;Eric K. Rowinsky;Ross C. Donehower;Scott H. Kaufmann

  • The rapamycin-sensitive signal transduction pathway as a target for cancer therapy

    Manuel Hidalgo;Eric K Rowinsky

  • Phase I Pharmacologic and Biologic Study of Ramucirumab (IMC-1121B), a Fully Human Immunoglobulin G1 Monoclonal Antibody Targeting the Vascular Endothelial Growth Factor Receptor-2

    Jennifer L. Spratlin;Roger B. Cohen;Matthew Eadens;Lia Gore

  • Ras Protein Farnesyltransferase: A Strategic Target for Anticancer Therapeutic Development

    Eric K. Rowinsky;Jolene J. Windle;Daniel D. Von Hoff

  • Multicenter Phase II and Translational Study of Cetuximab in Metastatic Colorectal Carcinoma Refractory to Irinotecan, Oxaliplatin, and Fluoropyrimidines

    Heinz Josef Lenz;Eric Van Cutsem;Shirin Khambata-Ford;Robert J. Mayer

  • Sequences of Taxol and Cisplatin: A Phase I and Pharmacologic Study

    E K Rowinsky;M R Gilbert;W P McGuire;D A Noe

  • Taxol: the first of the taxanes, an important new class of antitumor agents.

    Eric K. Rowinsky;Eric K. Rowinsky;Nicole Onetto;Nicole Onetto;Renzo M. Canetta;Renzo M. Canetta;Susan G. Arbuck;Susan G. Arbuck

  • Cardiac disturbances during the administration of taxol.

    Eric K. Rowinsky;William P. McGuire;Thomas Guarnieri;Jason S. Fisherman

  • The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics.

    Eric K. Rowinsky;Ross C. Donehower

Frequent Co-Authors

Ross C. Donehower
Ross C. Donehower Johns Hopkins University
David S. Ettinger
David S. Ettinger Johns Hopkins University
Scott H. Kaufmann
Scott H. Kaufmann Mayo Clinic
Sharyn D. Baker
Sharyn D. Baker The Ohio State University
Arlene A. Forastiere
Arlene A. Forastiere Johns Hopkins University
Manuel Hidalgo
Manuel Hidalgo Cornell University
Amita Patnaik
Amita Patnaik University of Chicago
Richard J. Jones
Richard J. Jones Johns Hopkins University
Alex A. Adjei
Alex A. Adjei Cleveland Clinic
Yung-Chi Cheng
Yung-Chi Cheng Yale University

External Links

Personal website of Eric K. Rowinsky

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine doesn’t always require pursuing a traditional MD. There are many alternative pathways and online degrees in healthcare offering flexibility, diverse roles, and quicker entry into the workforce.

Many students begin their medical careers through direct entry nursing programs that allow individuals with a bachelor’s degree (in any field) to transition into nursing quickly. For those interested in nursing but looking for less strenuous entry requirements, an lpn program without teas test can be a good option, bypassing standardized entrance exams.

Non-clinical healthcare roles are always in demand. Earning a degree from one of the best online medical billing and coding schools that accept fafsa allows students to work in the administrative backbone of healthcare, often fully online and with financial aid options. Similarly, moving into leadership roles is possible with healthcare administration degree programs available online, designed for both new entrants and working professionals seeking advancement.

These pathways provide practical alternatives for those seeking fulfilling healthcare careers without the lengthy commitment of medical school.

Best Scientists Citing Eric K. Rowinsky

Jos H. Beijnen

Jos H. Beijnen

Utrecht University

Publications: 91

Scott H. Kaufmann

Scott H. Kaufmann

Mayo Clinic

Publications: 88

Jan H.M. Schellens

Jan H.M. Schellens

Utrecht University

Publications: 79

Jennifer R. Grandis

Jennifer R. Grandis

University of California, San Francisco

Publications: 74

Jaap Verweij

Jaap Verweij

Erasmus University Rotterdam

Publications: 59

Maurie Markman

Maurie Markman

The University of Texas MD Anderson Cancer Center

Publications: 58

Robert L. Ferris

Robert L. Ferris

University of Pittsburgh

Publications: 57

Jan B. Vermorken

Jan B. Vermorken

University of Antwerp

Publications: 57

Everett E. Vokes

Everett E. Vokes

University of Chicago

Publications: 52

Paul M. Harari

Paul M. Harari

University of Wisconsin–Madison

Publications: 49

Clinton F. Stewart

Clinton F. Stewart

St. Jude Children's Research Hospital

Publications: 48

Alex A. Adjei

Alex A. Adjei

Cleveland Clinic

Publications: 46

Mark J. Ratain

Mark J. Ratain

University of Chicago

Publications: 45

Chandra P. Belani

Chandra P. Belani

Penn State Cancer Institute

Publications: 42

Alex Sparreboom

Alex Sparreboom

The Ohio State University

Publications: 41

Ezra E.W. Cohen

Ezra E.W. Cohen

University of California, San Diego

Publications: 40

Trending Scientists

Arvo Viltrop

Arvo Viltrop

Estonian University of Life Sciences

D. M. Veira

D. M. Veira

Agriculture and Agriculture-Food Canada

Laigeng Li

Laigeng Li

Chinese Academy of Sciences

Arye Rosen

Arye Rosen

Drexel University

W. Einar Mencl

W. Einar Mencl

Yale University

Jeffrey M. Bergelson

Jeffrey M. Bergelson

Children's Hospital of Philadelphia

Michel Diament

Michel Diament

Institut de Physique du Globe de Paris

Will Featherstone

Will Featherstone

Curtin University

Robin Dennell

Robin Dennell

University of Exeter

Henry W. Murray

Henry W. Murray

Cornell University

Andrew M. Rollins

Andrew M. Rollins

Case Western Reserve University

Zhiliang Zhang

Zhiliang Zhang

Norwegian University of Science and Technology

Alex Sprintson

Alex Sprintson

Texas A&M University

Michel Verdaguer

Michel Verdaguer

Sorbonne University

Thomas F. Miller

Thomas F. Miller

California Institute of Technology

Pascale Charpin

Pascale Charpin

French Institute for Research in Computer Science and Automation - INRIA

Related Medicine Rankings & Guides

2027 Best Nurse Practitioner Programs in Maryland – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Maryland – Accredited Schools Online & Campus
2027 Fastest Online Master's Degree in Healthcare Management Programs

2027 Fastest Online Master's Degree in Healthcare Management Programs
2027 Best Online CAHME-Accredited MHA Programs

2027 Best Online CAHME-Accredited MHA Programs
2027 Best Nursing Schools in Virginia – Accredited ADN, BSN, MSN Programs

2027 Best Nursing Schools in Virginia – Accredited ADN, BSN, MSN Programs
2027 Most Affordable LVN to RN Online Bridge Programs

2027 Most Affordable LVN to RN Online Bridge Programs
2027 Best Online RN to BSN Programs Without Statistics

2027 Best Online RN to BSN Programs Without Statistics
2027 Best Pharmacy Schools & Pharmacist Programs Requirements in Oklahoma: Online & Campus

2027 Best Pharmacy Schools & Pharmacist Programs Requirements in Oklahoma: Online & Campus
2027 Best Online DNP Programs Without Clinicals

2027 Best Online DNP Programs Without Clinicals
2026 Best RN to BSN Programs With No Clinicals

2026 Best RN to BSN Programs With No Clinicals
2027 Most Affordable Online Accelerated BSN Programs for Non-Nurses

2027 Most Affordable Online Accelerated BSN Programs for Non-Nurses
2027 Best One-Year Online PMHNP Programs

2027 Best One-Year Online PMHNP Programs
2027 Best Online MSN in Forensic Nursing Programs

2027 Best Online MSN in Forensic Nursing Programs
2027 Best Shortest Online DNP Programs

2027 Best Shortest Online DNP Programs
2027 Best Online Exercise Science Degree Programs

2027 Best Online Exercise Science Degree Programs
2027 Best Nurse Practitioner Programs in Arizona – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Arizona – Accredited Schools Online & Campus
2027 Best Online Nurse Practitioner Degree Programs

2027 Best Online Nurse Practitioner Degree Programs
2027 Best Online MSN Family Nurse Practitioner Programs

2027 Best Online MSN Family Nurse Practitioner Programs
2027 Best Nurse Practitioner Programs in New Jersey – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in New Jersey – Accredited Schools Online & Campus
2027 Easiest RN-to-BSN Online Programs

2027 Easiest RN-to-BSN Online Programs
2027 Fastest Online RN to MSN (No ADN Required) Bridge Programs

2027 Fastest Online RN to MSN (No ADN Required) Bridge Programs
2027 Best Online MSN/MBA Dual Degree Programs

2027 Best Online MSN/MBA Dual Degree Programs

Recently Published Articles

2027 DNP Interview Questions and How to Prepare

2027 DNP Interview Questions and How to Prepare
2027 Online Respiratory Care Therapy Bachelor's Degree Programs With 8-Week Classes

2027 Online Respiratory Care Therapy Bachelor's Degree Programs With 8-Week Classes
2027 Fintech Careers Growing Fastest in 2026

2027 Fintech Careers Growing Fastest in 2026
2027 Is a Business Degree Worth It?

2027 Is a Business Degree Worth It?
2027 What Can You Do With A Marketing Degree? Costs, Requirements & Opportunities

2027 What Can You Do With A Marketing Degree? Costs, Requirements & Opportunities
2027 Acute Care vs. Critical Care vs. Trauma Nurse Practitioner: Explaining the Difference

2027 Acute Care vs. Critical Care vs. Trauma Nurse Practitioner: Explaining the Difference
2027 Best Human Development and Family Studies Online Degree Programs

2027 Best Human Development and Family Studies Online Degree Programs
2027 Online Biology and Biological Sciences Bachelor's Degree Completion Programs for Working Adults

2027 Online Biology and Biological Sciences Bachelor's Degree Completion Programs for Working Adults
2027 Fastest Online Spanish Degree Programs You Can Finish in Under 2 Years

2027 Fastest Online Spanish Degree Programs You Can Finish in Under 2 Years
2027 Best Medical Assistant Schools & Programs in Arkansas – How to Become a Medical Assistant in Arkansas

2027 Best Medical Assistant Schools & Programs in Arkansas – How to Become a Medical Assistant in Arkansas
2027 Respiratory Care Therapy Degree Jobs That Do Not Require Licensure

2027 Respiratory Care Therapy Degree Jobs That Do Not Require Licensure
2027 No-Exam Online Fine Arts Master's Degrees: Schools, Costs & Outcomes

2027 No-Exam Online Fine Arts Master's Degrees: Schools, Costs & Outcomes
2027 Online Fashion Merchandising Master's Programs at Accredited U.S. Universities

2027 Online Fashion Merchandising Master's Programs at Accredited U.S. Universities
2027 Online Construction Management Bachelor's Degree Programs With Asynchronous Classes

2027 Online Construction Management Bachelor's Degree Programs With Asynchronous Classes
2027 Fastest Online Communication Disorders Degree Programs You Can Finish in Under 2 Years

2027 Fastest Online Communication Disorders Degree Programs You Can Finish in Under 2 Years
2027 How to Become a Mechanic in Texas: Requirements & Certification

2027 How to Become a Mechanic in Texas: Requirements & Certification
2027 Cryptographer Careers: Skills, Education, Salary & Job Outlook

2027 Cryptographer Careers: Skills, Education, Salary & Job Outlook
2027 Best Medical Assistant Schools & Programs in Virginia – How to Become a Medical Assistant in Virginia

2027 Best Medical Assistant Schools & Programs in Virginia – How to Become a Medical Assistant in Virginia
2027 Fastest Online Master's Programs in Business Law

2027 Fastest Online Master's Programs in Business Law
2027 Licensing Exams Required After Completing an Environmental Science Degree Program

2027 Licensing Exams Required After Completing an Environmental Science Degree Program
2027 How to Become a Nurse Practitioner – Salary & Requirements

2027 How to Become a Nurse Practitioner – Salary & Requirements